This is a registry record, not a result. A trial being listed, recruiting or completed says nothing by itself about whether the compound works or is safe.
| Registry number | NCT00428415 |
|---|---|
| Status | Completed |
| Phase | Phase 1 / Phase 2 |
| Sponsor | NeuroSearch A/S |
| Enrollment | 32 participants |
| Design | Interventional, Randomized, Parallel, Masking: Double |
| Conditions | Obesity |
| Interventions | Tesofensine |
| Start | Mar 2007 |
| Primary completion | Dec 2007 |
| Study completion | Dec 2007 |
| Results posted | Not yet |
| Registry last updated | Mar 5, 2008 |
Compounds on this site that cite this trial
What the registry says the trial is about
Purpose:
To evaluate the effect of tesofensine on energy balance
Primary outcomes
These are what the trial was designed to measure first. They are registered in advance, which is what makes a later result checkable.
| Outcome measure | Time frame |
|---|---|
| Effect on 24-h EE (energy expenditure) after 14 days dosing, adjusted for FFM(Fat-Free Mass) and FM (Fat Mass) changes |
5 secondary outcomes also registered. See the registry record for the full list.
Source: ClinicalTrials.gov (U.S. National Library of Medicine). Last checked against the registry on Oct 3, 2026. See the trial changes feed for what has changed recently.
